Recent Analyst Forecasts and Stock Ratings
Marinus Pharmaceuticals, Inc. FAQ's
Marinus Pharmaceuticals, Inc. has been rated by research analysts at Oppenheimer, Robert W. Baird, RBC Capital in the past 90 days.
Marinus Pharmaceuticals, Inc. has been rated by research analysts at Oppenheimer, Robert W. Baird, RBC Capital in the past 90 days.